Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.
Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo
Alemtuzumab
The challenge of comorbidity in clinical trials for multiple sclerosis.
Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis.
GEMS Project: A Platform to Investigate Multiple Sclerosis Risk.
NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.
ARESTIN®
Federation of Clinical Immunology Societies 2012
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
B cells and multiple sclerosis.
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
One can prevent post-partum MS relapses by exclusive breast feeding: no.
[Experience of using genfaxon for treating patients with relapsing-remitting multiple sclerosis in the Russian Federation.]
4th Biannual NeuroUnit Biomarkers for Inflammation and Neurodegeneration Symposium on Biomarkers in Neurodegenerative Disease
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events.
lambda-Interferons and the single nucleotide polymorphisms: A milestone to tailor-made therapy for chronic hepatitis C.
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.
Interferon Beta-1b may reverse axonal dysfunction in multiple sclerosis.
Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis.
Background information on multiple sclerosis patients stopping ongoing immunomodulatory therapy: a multicenter study in a community-based environment.
Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Glatiramer acetate ameliorates experimental autoimmune neuritis.
Pregnancy outcomes in patients exposed to interferon beta-1b.

Pages